an24249196-8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 

Date of Report (Date of earliest event reported):  September 19, 2011

AngioDynamics, Inc.
(Exact Name of Registrant as Specified in Charter)


Delaware
 
000-50761
11-3146460
(State or Other Jurisdiction of
 Incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)
 

14 Plaza Drive, Latham, New York
 
12110
(Address of Principal Executive Offices)
 (Zip Code)

 
(518) 798-1215
 
(Registrant’s telephone number, including area code)
 
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 

 
 
 

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 19, 2011, Scott J. Solano resigned his position as Senior Vice President and Chief Technology Officer of AngioDynamics, Inc. (the “Company”) effective October 14, 2011.  Mr. Solano will not receive any severance or termination payments from the Company in connection with his resignation.

Item 9.01 – Financial Statements and Exhibits.

(d)               Exhibits.
 

 Exhibit No.
  
Description
 
99.1
  
 
Press Release dated September 22, 2011.

 
 
 


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
ANGIODYNAMICS, INC.
(Registrant)
  
       
       
Date: September 22, 2011
By:
/s/ D. Joseph Gersuk  
    D. Joseph Gersuk  
    Chief Financial Officer  
       
 

 
 
 


EXHIBIT INDEX

 Exhibit No.
  
Description
 
99.1
  
 
Press Release dated September 22, 2011.